| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Viking Therapeutics, Inc. (VKTX) has 8 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. VKTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $85.66M | -148,517 | |
| COO | 422.8K | $14.08M | -18,217 | |
| CFO | 212.2K | $7.07M | -21,217 | |
| Dir | 148.0K | $4.93M | - | |
| Dir | 51.1K | $1.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 29, 2018 | Rowland Charles A Jr46 | Director | Buy | 30,000 | $5.16 | $154,800.00 | New | |
| May 29, 2018 | Webster Stephen W | Director | Buy | 8,000 | $5.21 | $41,712.00 | New | |
| May 29, 2018 | MacArtney Lawson | Director | Buy | 47,965 | $5.22 | $250,329.34 | New | |
| Nov 15, 2016 | Foehr Matthew W72 | Director | Buy | 13,000 | $1.21 | $15,678.00 | +49.5% | |
| Apr 13, 2016 | Foehr Matthew W72 | Director | Buy | 20,000 | $1.24 | $24,800.00 | +320.0% | |
| May 4, 2015 | Foehr Matthew W72 | Director | Buy | 6,250 | $8.00 | $50,000.00 | New |